Clinical Trials Directory

Trials / Completed

CompletedNCT03347903

Prevalence and Clinical Characteristics of Patients With Jackhammer Esophagus and Symptoms of Gastroesophageal Reflux Disease

Status
Completed
Phase
Study type
Observational
Enrollment
37 (actual)
Sponsor
Medical University of Vienna · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers

Summary

Gastroesophageal reflux disease (GERD) is involved in the development of esophageal motility disorders like Jackhammer esophagus (JE), a novel hypercontractile condition that was associated with progression to achalasia and limited outcomes following surgical anti-reflux therapy. This trial was designed to assess the prevalence and characteristics of JE in patients with typical symptoms of GERD and responsiveness to PPI therapy.

Detailed description

Jackhammer esophagus is a novel hypercontractile esophageal disorder. The investigators assess the prevalence and clinical characteristics of patients diagnosed with this disorder out of a collective of patients that are referred with symptoms of gastroesphageal reflux disease and respond to PPI. This is an observational trial.

Conditions

Timeline

Start date
2014-01-01
Primary completion
2017-05-30
Completion
2017-05-30
First posted
2017-11-20
Last updated
2017-11-21

Source: ClinicalTrials.gov record NCT03347903. Inclusion in this directory is not an endorsement.